Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to ...
A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...
ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...
Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...
NEW TECHNOLOGY: The new HYDROS™ Robotic System is the next-generation platform to treat men suffering from benign prostatic hyperplasia. (Submitted Photo) THOMASVILLE — Archbold is now offering ...
DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback